Stocks · Health care · Surgical & Medical Instruments & Apparatus

GLOBUS MEDICAL INC

GMED Clue Score76
United States Fiscal year ends December CIK 0001237831 Results filed 5 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Ann D Rhoads
4 Nov 2026
Director
Sold on a plan
5,000
$85.00
$425.00K
James R Tobin
15 Sep 2026
Director
Sold after exercise
30,000
$74.58
$2.24M
Stephen T Zarrilli
18 Aug 2026
Director
Sold after exercise
25,000
$87.04
$2.18M
David D Davidar
5 Jun 2026
Director
Sold after exercise
25,000
$80.76
$2.02M
Ann D Rhoads
4 Jun 2026
Director
Exercised, kept
25,000
$26.27
$656.75K
Kelly Huller
25 Feb 2026
EVP, GC, Corporate Secretary
Sold after exercise
20,000
$94.50
$1.89M
Kelly Huller
12 Feb 2026
EVP, GC, Corporate Secretary
Sold after exercise
10,000
$87.67
$876.70K
Leslie Norwalk V
8 Jan 2026
Director
Sold on a plan
2,000
$101.10
$202.20K
Kyle Kline
8 Jan 2026
Senior Vice President, CFO
Sold after exercise
3,594
$101.10
$363.35K
Leslie Norwalk V
12 Dec 2025
Director
Sold on a plan
4,000
$88.85
$355.40K
David C Paul
8 Dec 2025
Executive Chairman
Exercised, kept
34,375
$25.52
$877.25K
Kyle Kline
1 Dec 2025
Senior Vice President, CFO
Sold after exercise
18,542
$90.00
$1.67M
Kelly Huller
25 Nov 2025
SVP, GC, Corporate Secretary
Sold after exercise
7,500
$90.00
$675.00K
David D Davidar
12 Nov 2025
Director
Sold after exercise
25,000
$86.00
$2.15M
Stephen T Zarrilli
11 Nov 2025
Director
Sold after exercise
25,000
$84.29
$2.11M
Ann D Rhoads
10 Nov 2025
Director
Sold on a plan
2,000
$85.00
$170.00K
Ann D Rhoads
7 Nov 2025
Director
Sold on a plan
8,000
$81.00
$648.00K

What was left out

Form 4 filings counted 31
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 10
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 251,511
History held since 10 Aug 2012